These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31435929)

  • 1. Construction of a Macrophage-Targeting Bio-nanocapsule-Based Nanocarrier.
    Li H; Somiya M; Tatematsu K; Kuroda S
    Methods Mol Biol; 2020; 2059():299-313. PubMed ID: 31435929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.
    Li H; Tatematsu K; Somiya M; Iijima M; Kuroda S
    Acta Biomater; 2018 Jun; 73():412-423. PubMed ID: 29673839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
    Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
    Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
    Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
    J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
    Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
    Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of Nanoparticles Harboring Recombinant Large Surface Protein of Hepatitis B Virus to Scavenger Receptor Class B Type 1.
    Hinuma S; Fujita K; Kuroda S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.
    Matsuo H; Yoshimoto N; Iijima M; Niimi T; Jung J; Jeong SY; Choi EK; Sewaki T; Arakawa T; Kuroda S
    Int J Nanomedicine; 2012; 7():3341-50. PubMed ID: 22848163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection.
    Miyata T; Tafuku S; Harakuni T; Tadano M; Yoshimoto N; Iijima M; Matsuo H; Matsuzaki G; Kuroda S; Arakawa T
    Microbiol Immunol; 2013 Jun; 57(6):470-7. PubMed ID: 23773026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.
    Kasuya T; Jung J; Kinoshita R; Goh Y; Matsuzaki T; Iijima M; Yoshimoto N; Tanizawa K; Kuroda S
    Methods Enzymol; 2009; 464():147-66. PubMed ID: 19903554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
    Jung J; Somiya M; Jeong SY; Choi EK; Kuroda S
    Nanomedicine; 2018 Feb; 14(2):595-600. PubMed ID: 29175598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule.
    Somiya M; Kuroda S
    Adv Drug Deliv Rev; 2015 Dec; 95():77-89. PubMed ID: 26482188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.
    Jung J; Matsuzaki T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
    J Control Release; 2008 Mar; 126(3):255-64. PubMed ID: 18207275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DDS Nanocarriers Mimicking Early Infection Machinery of Viruses].
    Somiya M; Kuroda S
    Yakugaku Zasshi; 2020; 140(2):147-152. PubMed ID: 32009036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered bio-nanocapsules, the selective vector for drug delivery system.
    Yu D; Fukuda T; Tuoya ; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada T; Tada H; Seno M
    IUBMB Life; 2006 Jan; 58(1):1-6. PubMed ID: 16596748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells.
    Matsuo H; Somiya M; Iijima M; Arakawa T; Kuroda S
    J Nanobiotechnology; 2018 Aug; 16(1):59. PubMed ID: 30077180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oriented immobilization to nanoparticles enhanced the therapeutic efficacy of antibody drugs.
    Iijima M; Araki K; Liu Q; Somiya M; Kuroda S
    Acta Biomater; 2019 Mar; 86():373-380. PubMed ID: 30641288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.
    Liu Q; Somiya M; Kuroda S
    World J Gastroenterol; 2016 Oct; 22(38):8489-8496. PubMed ID: 27784961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of arginine-rich peptide displaying bionanocapsules.
    Shishido T; Yonezawa D; Iwata K; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1473-6. PubMed ID: 19200722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional membrane scaffold for the oriented immobilization of biosensing molecules.
    Iijima M; Nakayama T; Kuroda S
    Biosens Bioelectron; 2020 Feb; 150():111860. PubMed ID: 31735623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.